RxDoctor Payments DataLook up a doctor →

William Schiff, MD

Urology · Fresno, CANPI 1629073226

Payments from drug & device makers

$314,630in general payments, 2019–2025

Across 220 payments — averaging $1430.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dendreon Pharmaceuticals LLC$84K
  • Ferring Pharmaceuticals AS$82K
  • Sumitomo Pharma America, Inc.$59K
  • Janssen Research & Development, LLC$39K
  • Olympus Corporation Of The Americas$34K
  • Gyrus ACMI, Inc.$9K
  • plus $8K from 35 others
$14,644in research payments, 2019–2025

Across 2 payments — averaging $7322.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Dendreon Pharmaceuticals LLC$15K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$314,630 in reported general payments places this provider in the 95th percentile of 1,324 urology providers in California.

See all urology providers in California

Medicare billing

Part B allowed, 2024
$1,116,880
Medicare patients
1,005
Services billed
26,572

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Fresno

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →